Market Overview

Benzinga's Top Initiations

Benzinga's Top Initiations
The First US-Listed Marijuana ETF Ignites Today
Citigroup Reinstates Coverage Of Bats Global Markets Ahead Of Q3 Earnings
Related CTAS
Jim Cramer Shares His Thoughts On Merck, Five Below And More
Analyst: Here's Why Cintas Stock Fell Despite A Quarterly Beat-And-Raise

Janney Capital initiated coverage on Sarepta Therapeutics Inc (NASDAQ: SRPT) with a Neutral rating. The target price for Sarepta Therapeutics is set to $19. Sarepta Therapeutics shares closes at $20.86 on Tuesday.

BB&T Capital initiated coverage on Ulta Salon, Cosmetics & Fragrance, Inc. (NASDAQ: ULTA) with a Hold rating. Ulta Salon shares closed at $204.04 on Tuesday.

Analysts at Nomura initiated coverage on Cintas Corporation (NASDAQ: CTAS) with a Buy rating. The target price for Cintas is set to $102. Cintas shares fell 0.01 percent to close at $90.47 on Tuesday.

Analysts at Raymond James initiated coverage on BATS Global Markets, Inc. (BATS: BATS) with a Underperform rating. BATS Global Markets closed at $23.41 on Tuesday.

Latest Ratings for BATS

Oct 2016CitigroupReinstatesNeutral
Oct 2016JefferiesMaintainsHold
Sep 2016Goldman SachsMaintainsNeutral

View More Analyst Ratings for BATS
View the Latest Analyst Ratings

Posted-In: Top InitiationsInitiation Analyst Ratings


Related Articles (CTAS + BATS)

View Comments and Join the Discussion!